Suchergebnisse - "Kaufman, Jonathan L"

PubPharm (160)

1

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

enthalten in: Blood cancer journal | 2024

von Callander, N. | Silbermann, R. | Kaufman, J. | +33

2

Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone : Patient-reported outcomes from GRIFFIN

enthalten in: American journal of hematology | 2024

von Silbermann, R. | Laubach, J. | Kaufman, J. | +23

3

Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study

enthalten in: British journal of haematology | 2024

von Nooka, A. | Kaufman, J. | Rodriguez, C. | +16

4

Glücksklee, the Quad, and High-Risk Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Nooka, A. | Kaufman, J. | Lonial, S.

5

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab : A single-center experience

enthalten in: Blood cancer journal | 2023

von Scott, S. | Marin, E. | Maples, K. | +7

6

Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast

enthalten in: The oncologist | 2023

von Lalonde, C. | Switchenko, J. | Behera, M. | +11

7

Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN) : final analysis of an open-label, randomised, phase 2 trial

enthalten in: The Lancet. Haematology | 2023

von Voorhees, P. | Sborov, D. | Laubach, J. | +25

CommentIn: Lancet Haematol. 2023 Oct;10(10):e788-e789. - PMID 37793762

8

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma : Impact of hybrid immunity

enthalten in: Research square | 2023

von Moreno, A. | Manning, K. | Azeem, M. | +12

9

Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction

enthalten in: JCO oncology practice | 2023

von Sun, L. | Maples, K. | Hall, K. | +9

10

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

enthalten in: bioRxiv.org | 2023

von Moreno, A. | Manning, K. | Azeem, M. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]